HORIZON EUROPE
European
ExpectedOutcome:Multi-functional biomaterials are capable, by virtue of their own material ingredients or surface properties, of achieving several biological responses simultaneously. They may also help to dampen those that are undesirable such as inflammation, infection, corrosion and issues related to bio and immune compatibility, while taking into account the specificities due to sex, race and age.
Projects are expected to contribute to the following outcomes:
Offer solutions through the development of multifunctional biomaterials to address and mitigate multiple bottlenecks in response to unmet clinical needs;Provide improved biocompatibility, biospecificity and longevity of medical devices or if relevant, improved bioactivity and/or biodegradability; physiological and biomechanical constraints and implications should also be considered.Show that the regulatory and IPR strategies are compatible with the overall research objectives.
Scope:Multifunctional biomaterials play a major part in shaping the future of Advanced Therapies and Medical Devices. Health applications may include but are not limited to tissue engineering, artificial organs, impl...
see more
ExpectedOutcome:Multi-functional biomaterials are capable, by virtue of their own material ingredients or surface properties, of achieving several biological responses simultaneously. They may also help to dampen those that are undesirable such as inflammation, infection, corrosion and issues related to bio and immune compatibility, while taking into account the specificities due to sex, race and age.
Projects are expected to contribute to the following outcomes:
Offer solutions through the development of multifunctional biomaterials to address and mitigate multiple bottlenecks in response to unmet clinical needs;Provide improved biocompatibility, biospecificity and longevity of medical devices or if relevant, improved bioactivity and/or biodegradability; physiological and biomechanical constraints and implications should also be considered.Show that the regulatory and IPR strategies are compatible with the overall research objectives.
Scope:Multifunctional biomaterials play a major part in shaping the future of Advanced Therapies and Medical Devices. Health applications may include but are not limited to tissue engineering, artificial organs, implants, bioinks for bioprinting platforms, microfluidics, bioactive scaffolds, wearable and implantable devices, in-vitro diagnostics etc.
Projects funded under this topic should further:
Develop and/or validate specific multifunctional biomaterials or micro systems for use in an eventual advanced therapy, medicinal product or medical device;Preclinical regulatory affairs as well as manufacturing processes would also need to be addressed, including up-scaling and good manufacturing practice (GMP);Pay special attention to the needs of Small and Medium-Sized Enterprises (SMEs) as well as to the ultimate clinical applications of these biomaterials;Present a solid economical evaluation of possible savings, together with patient benefits. Proposals submitted under this topic should include a business case and exploitation strategy, as outlined in the introduction to this Destination.
This topic is open for international cooperation where the EU has reciprocal benefit, while excluding industrial competitors from countries where the safeguarding of IPRs cannot be guaranteed.
Specific Topic Conditions:Activities are expected to start at TRL 3 and achieve TRL 5 by the end of the project – see General Annex B.
Cross-cutting Priorities:Digital AgendaInternational CooperationArtificial Intelligence
see less
Consortium characteristics
:
The aid is European, you can apply to this line any company that is part of the European Community.
characteristics of the Proyecto
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Characteristics of financing
Additional information about the call
other advantages
similar aids
| Abierta
| Próximamente